An article from
News roundup
Eli Lilly and Astellas will be the lead bidders at an auction for Sangamo assets. Elsewhere, Merck KGaA struck a “build-to-buy” deal with a new Versant Ventures startup.
Published June 24, 2026
Getty Images
Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor
Eli Lilly and Astellas will be the lead bidders at an auction for Sangamo assets. Elsewhere, an investor syndicate committed $230 million to a gene editing startup and Merck KGaA struck a “build-to-buy” deal.
545 words~2 min read
